On May 17, 2023, ProQR Therapeutics N.V. held its 2023 annual general meeting of shareholders. ProQR shareholders approved the appointment of Theresa Heggie and Begoña Carreño as Supervisory Board member.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.985 USD | +2.32% | -0.75% | +0.25% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.25% | 158M | |
-2.32% | 103B | |
+1.44% | 95.28B | |
+2.53% | 22.15B | |
-15.79% | 21.02B | |
-8.38% | 18.15B | |
-41.01% | 16.73B | |
-13.53% | 16.05B | |
+3.91% | 13.68B | |
+34.80% | 12.17B |
- Stock Market
- Equities
- PRQR Stock
- News ProQR Therapeutics N.V.
- ProQR Therapeutics N.V. Approves the Appointment of Theresa Heggie and Begoña Carreño as Supervisory Board Member